DRMAW Dermata Therapeutics, Inc. - Warrant
DRMAW Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
DRMAW Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $8M | $4M | $6M | $3M | $2M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $2M | |
| Operating Expenses | $8M | $13M | $8M | $10M | · | · | |
| Operating Income | $-8M | $-13M | $-8M | $-10M | $-8M | $-3M | |
| Interest Expense | · | · | · | · | $45.6K | $197.3K | |
| Interest Income | $215.0K | $225.8K | · | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-12M | $-8M | $-10M | $-8M | $-3M | |
| EPS (Basic) | $-8.16 | $-80.32 | $-39.99 | $-13.92 | $-2.43 | $-1.69 | |
| EPS (Diluted) | $-8.16 | $-80.32 | $-39.99 | · | · | · | |
| Shares (Basic) | 926,192 | 152,974 | · | · | 4,302,232 | 1,911,009 | |
| Shares (Diluted) | 926,192 | 152,974 | 194,928 | · | · | · | |
| EBITDA | $-8M | $-13M | $-8M | · | $-8M | · |
Stato Patrimoniale 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | · | $6M | $11M | $530.4K | |
| Prepaid Expense | $341.8K | $372.3K | $540.5K | $703.2K | $825.1K | $75.1K | |
| Current Assets | $8M | · | · | · | $12M | $605.5K | |
| PP&E (Net) | · | · | · | · | $0 | $0 | |
| Total Assets | $8M | $4M | $8M | $7M | $12M | $605.5K | |
| Accounts Payable | $460.8K | $808.0K | $866.0K | $496.7K | $515.2K | $104.3K | |
| Current Liabilities | · | · | · | · | $2M | $4M | |
| Total Liabilities | $2M | $2M | $2M | $922.6K | $2M | $4M | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $266 | $25 | $26 | $77 | $833 | $0 | |
| Paid-in Capital | $79M | $67M | $60M | $52M | $46M | $0 | |
| Retained Earnings | $-73M | $-66M | $-53M | $-46M | $-36M | $-28M | |
| Stockholders' Equity | $6M | $2M | $6M | $6M | $10M | $-3M | |
| Liabilities + Equity | $8M | $4M | $8M | $7M | $12M | $605.5K | |
| Shares Outstanding | 2,660,110 | 251,725 | 261,998 | 770,115 | 8,328,629 | · |
Flusso di cassa 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $0 | $322 | |
| Stock-based Comp | $143.7K | $657.6K | $522.1K | $930.3K | $2M | $0 | |
| Operating Cash Flow | $-8M | $-11M | $-6M | $-9M | $-6M | $-4M | |
| Stock Issued | $12M | $7M | $8M | $4M | $15M | · | |
| Net Stock Activity | $12M | $7M | $8M | · | · | · | |
| Financing Cash Flow | $12M | $7M | $8M | $4M | $16M | $3M | |
| Net Change in Cash | $4M | $-4M | · | · | $10M | $-1M |
Redditività 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -132.6% | -213.5% | -104.5% | · | -129.2% | · | |
| ROE | -127.7% | -389.9% | -122.2% | · | -69.9% | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 7.7 | · | |
| Quick Ratio | · | · | · | · | 7.1 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| Interest Coverage | · | · | · | · | -172.3 | · |
Valutazione (TTM) 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $182.8K | $182.8K | $182.8K | $63.6K | $-45.6K | · | |
| Net Income TTM | $-8M | $-12M | $-8M | $-10M | $-8M | · |
Conto Economico 11
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $212.6K | $383.7K | $526.6K | $504.4K | $617.8K | $1M | $2M | $2M | $2M | $2M | $1M | $903.0K | $838.9K | $1M | $889.4K | $2M | |
| SG&A Expense | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $824.3K | $874.6K | $2M | $1M | $909.0K | $893.5K | $1M | $822.3K | $892.8K | |
| Operating Expenses | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | |
| Interest Income | $46.5K | $78.7K | $38.5K | $68.7K | $71.6K | $36.2K | $49.4K | $52.5K | $54.6K | $69.3K | · | · | · | · | · | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | |
| EPS (Basic) | $-0.74 | $-0.48 | $-4.40 | $-1.65 | $-1.22 | $-4.47 | $-11.03 | $-20.41 | $-41.82 | $-7.06 | $-36.55 | $-0.54 | $-0.63 | $-2.27 | $-6.53 | $-3.16 | |
| EPS (Diluted) | $-0.74 | $-0.48 | $-4.40 | $-1.65 | $-1.66 | $-4.47 | $-11.03 | $-20.41 | $-41.82 | $-7.06 | · | · | · | · | · | · | |
| Shares (Basic) | 4,022,143 | 3,858,921 | -6,281,469 | 1,026,457 | 1,026,506 | 515,465 | -514,143 | 155,465 | 67,654 | 443,998 | · | · | · | · | · | · | |
| Shares (Diluted) | 4,022,143 | 3,858,921 | -6,281,469 | 1,026,457 | 1,026,506 | 515,465 | -514,143 | 155,465 | 67,654 | 443,998 | · | · | · | · | · | · | |
| EBITDA | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-2M | · | $-2M |
Stato Patrimoniale 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $8M | $5M | $6M | $10M | $3M | · | · | · | · | $7M | $8M | $9M | · | $8M | |
| Inventory | $149.7K | $93.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $593.6K | $427.3K | $341.8K | $407.3K | $159.6K | $285.7K | $372.3K | $543.6K | $289.5K | $446.1K | $540.5K | $691.9K | $274.4K | $528.3K | $703.2K | $908.1K | |
| Current Assets | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Net) | $129.4K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $5M | $7M | $8M | $5M | $7M | $10M | $4M | $7M | $5M | $5M | $8M | $7M | $9M | $9M | $7M | $9M | |
| Accounts Payable | $1M | $318.3K | $460.8K | $453.4K | $413.7K | $1M | $808.0K | $863.6K | $1M | $822.5K | $866.0K | $474.5K | $437.8K | $492.9K | $496.7K | $483.7K | |
| Total Liabilities | $2M | $1M | $2M | $1M | $1M | $3M | $2M | $2M | $2M | $1M | $2M | $916.8K | $682.9K | $1M | $922.6K | $2M | |
| Common Stock | $402 | $402 | $266 | $84 | $64 | $603 | $25 | $168 | $69 | $666 | $26 | $319 | $319 | $239 | $77 | $1.2K | |
| Paid-in Capital | $82M | $81M | $79M | $75M | $75M | $75M | $67M | $67M | $63M | $60M | $60M | $58M | $58M | $56M | $52M | $51M | |
| Retained Earnings | $-78M | $-75M | $-73M | $-71M | $-70M | $-68M | $-66M | $-63M | $-59M | $-57M | $-53M | $-51M | $-50M | $-48M | $-46M | $-44M | |
| Stockholders' Equity | $3M | $6M | $6M | $4M | $6M | $7M | $2M | $5M | $3M | $4M | $6M | $6M | $8M | $8M | $6M | $7M | |
| Liabilities + Equity | $5M | $7M | $8M | $5M | $7M | $10M | $4M | $7M | $5M | $5M | $8M | $7M | $9M | $9M | $7M | $9M | |
| Shares Outstanding | 4,022,143 | 4,022,143 | 2,660,110 | 844,457 | 637,757 | 6,032,648 | 251,725 | 1,677,768 | 693,175 | 6,660,840 | 261,998 | 3,189,034 | 3,189,034 | 2,388,157 | 770,115 | 12,102,214 |
Flusso di cassa 6
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41.8K | $43.3K | $29.5K | $37.8K | $39.2K | $37.2K | $29.8K | $21.0K | $19.6K | $587.2K | $128.5K | $131.2K | $131.2K | $131.3K | $220.9K | $235.0K | |
| Operating Cash Flow | $-2M | $-2M | $-1M | $-2M | $-3M | $-2M | $-3M | $-3M | $-2M | $-3M | $-1M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Stock Issued | · | · | $4M | $-12.6K | $-547.9K | $9M | $-69.5K | $5M | $2M | · | $2M | $-35.4K | $2M | $4M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $9M | · | · | · | $0 | · | · | · | $4M | · | · | |
| Financing Cash Flow | $-323 | $2M | $4M | $-13.0K | $-547.9K | $8M | $-68.6K | $5M | $2M | · | $2M | $-35.4K | $2M | $4M | $0 | $200 | |
| Net Change in Cash | $-3M | $-576.7K | $3M | $-2M | $-3M | $7M | $-3M | $1M | $213.4K | $-3M | · | · | · | · | · | · |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -1953.3% | -5579.4% | -6067.3% | · | 11384.5% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -1853.3% | -5479.4% | -5967.3% | · | 11284.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -1953.3% | -5579.4% | -6067.3% | · | 11384.5% | |
| ROA | -49.6% | -21.1% | · | -28.8% | -28.6% | -30.3% | · | -45.3% | -40.6% | -43.3% | · | -21.1% | -17.2% | -24.4% | · | -21.4% | |
| ROE | -65.2% | -27.0% | · | -38.9% | -38.1% | -41.5% | · | -56.9% | -49.9% | -52.7% | · | -24.8% | -19.2% | -28.1% | · | -24.3% |
Efficienza 1
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | -0.0 |
Valutazione (TTM) 9
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $182.8K | $182.8K | · | $182.8K | $182.8K | $182.8K | · | $182.8K | $182.8K | $182.8K | · | $182.8K | $90.1K | $59.0K | · | $22.1K | |
| Net Income TTM | $-8M | $-8M | · | $-9M | $-10M | $-11M | · | $-11M | $-9M | $-9M | · | $-8M | $-9M | $-10M | · | $-10M | |
| Market Cap | $73.6K | $73.6K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.4 | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -24754.1% | -45136.6% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-8M | $-12M | $-8M | $-10M | $-8M |
| EPS Diluito | $-8.16 | $-80.32 | $-39.99 | — | — |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | — | — | — | — | 0.0 |
| Rapporto corrente | — | — | — | — | 7.7 |
| Quick Ratio | — | — | — | — | 7.1 |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 3 filer · $15K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 1 (0 vs trimestre precedente) | 0 (-1 vs trimestre precedente) | 1 (+1 vs trimestre precedente) | 0 (0 vs trimestre precedente) | +12K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $15.480 | 12.000 | 99,88% | Azioni |
| UBS Group AG | $18 | 1.804 | 0,12% | Azioni |
| Virtu Financial LLC | $0 | 11.029 | 0,00% | Azioni |
Insider aziendali 3 insider · 2 dirigenti · 2 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | 16 Agosto 2026 A | 292.631 | 0 | 0 | $0 |
| Kyri K. Van Hoose | SVP, CFO | 16 Agosto 2026 A | 232.463 | 0 | 0 | $0 |
| Kathleen D. Scott | Direttore | 16 Giugno 2026 S | 0 | 0 | 1 | $-13 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato